These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 15019179

  • 1. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW, Garner RC.
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [Abstract] [Full Text] [Related]

  • 2. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
    Wild CP, Hasegawa R, Barraud L, Chutimataewin S, Chapot B, Ito N, Montesano R.
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
    [Abstract] [Full Text] [Related]

  • 3. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats.
    Tang L, Guan H, Ding X, Wang JS.
    Toxicol Appl Pharmacol; 2007 Feb 15; 219(1):10-7. PubMed ID: 17229449
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
    Dingley KH, Freeman SP, Nelson DO, Garner RC, Turteltaub KW.
    Drug Metab Dispos; 1998 Aug 15; 26(8):825-8. PubMed ID: 9698300
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
    Scholl PF, McCoy L, Kensler TW, Groopman JD.
    Chem Res Toxicol; 2006 Jan 15; 19(1):44-9. PubMed ID: 16411655
    [Abstract] [Full Text] [Related]

  • 10. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
    Scholl PF, Turner PC, Sutcliffe AE, Sylla A, Diallo MS, Friesen MD, Groopman JD, Wild CP.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr 15; 15(4):823-6. PubMed ID: 16614131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
    Turteltaub KW, Vogel JS, Frantz C, Felton JS, McManus M.
    Princess Takamatsu Symp; 1995 Apr 15; 23():93-102. PubMed ID: 8844800
    [Abstract] [Full Text] [Related]

  • 13. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
    Egner PA, Yu X, Johnson JK, Nathasingh CK, Groopman JD, Kensler TW, Roebuck BD.
    Chem Res Toxicol; 2003 Sep 15; 16(9):1174-80. PubMed ID: 12971806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.
    Wild CP, Jiang YZ, Sabbioni G, Chapot B, Montesano R.
    Cancer Res; 1990 Jan 15; 50(2):245-51. PubMed ID: 2104776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E, Schuler D, Budiawan.
    IARC Sci Publ; 1999 Jan 15; (150):219-32. PubMed ID: 10626223
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.